Contact this trialFirst, we need to learn more about you.
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
Saxagliptin for Type 2 Diabetes
Recruiting3 awardsPhase 3
Kansas City, Missouri
The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service